Regulation - Research, Astellas Pharma

Filter

Current filters:

ResearchAstellas Pharma

Popular Filters

AVEO and Astellas’ tivozanib beats sorafenib in Ph III TIVO-1 trial

04-01-2012

US cancer drug developer AVEO Pharmaceuticals (Nasdaq: AVEO)) and partner Japanese drug major Astellas…

Astellas PharmaAVEO PharmaceuticalsBayerBiotechnologyNephrology and HepatologyNexavarOncologyPharmaceuticalRegulationResearchtivozanib

Astellas drops development of blood thinner darexaban

29-09-2011

Japanese drug major Astellas Pharma (TYO: 4503) says it has decided to discontinue the global development…

Astellas PharmaCardio-vasculardarexabanPharmaceuticalRegulationResearch

Back to top